Glucocorticoid use and melanoma risk

International Journal of Cancer

Volumn 94, Issue 2, 2001, Pages 302-303

  Landi, Maria Teresa ^a   Baccarelli, Andrea ^a   Calista, Donato ^b   Fears, Thomas R ^c   Landi, Giorgio ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c BUFALINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RISK ASSESSMENT;

CASE-CONTROL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MELANOMA; RISK FACTORS; SKIN NEOPLASMS; SUNLIGHT;

EID: 0035888174     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1468     Document Type: Letter

References (19)

1. Suppression of growth of mouse melanoma by cortisone
2. Growth inhibition by glucocorticoids in RPMI 3460 melanoma cells
3. In vitro growth inhibition of human malignant melanoma cells by glucocorticoids
4. Dexamethasone, prostaglandin A, and retinoic acid modulation of murine and human melanoma cells grown in soft agar
5. Glucocorticoid receptors and cell cycle progression in human melanoma cell lines
6. Inhibition of growth of B16 melanoma by glucocorticoids does not result directly from receptor-mediated inhibition of tumour cells
7. Glucocorticoid receptors and the effect of glucocorticoids on the growth of B16 melanoma
8. Modulation of growth of melanoma
9. Characterization of corticotropin-releasing hormone (CRH) in human skin
10. Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin
11. A selective protein kinase C inhibitor (CGP 41251) positively and negatively modulates melanoma cell MSH receptors
12. The adrenal cortex
13. Eruptive nevi in Addison's disease
14. Neuroendocrinology of the skin
15. Loss of glucocorticoid receptors in B16BL6 murine melanoma associated with serial transplantation, metastatic selection and altered growth properties
16. Melanoma in organ transplant patients
17. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
18. Phase I clinical study of 6 methylpregn-4-ene-3,11,20-trione (NSC-17256)
19. Glucocorticoid-induced exacerbation of metastatic human melanoma